Top FDA official seeks to hire friend pushing new antidepressants warning - Top-Institutions - MDSpire

Top FDA official seeks to hire friend pushing new antidepressants warning

  • By

  • Matthew Perrone

  • March 4, 2026

  • 0 min

Share

Top Institutions in Obgyn

Brief introduction explaining scope and methodology.

  • #1

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, MA

    Key Differentiators

    • Psychiatry
    • Maternal-Fetal Medicine
    • Pharmacology

  • #2

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Psychiatry
    • Maternal-Fetal Medicine
    • Epidemiology

  • #3

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Psychiatry
    • Maternal-Fetal Medicine
    • Neurodevelopmental Research

  • #4

    University of Pennsylvania Perelman School of Medicine
    University of Pennsylvania Perelman School of Medicine

    Philadelphia, PA

    Key Differentiators

    • Psychiatry
    • Maternal-Fetal Medicine
    • Pharmacology

  • #5

    University of Washington
    University of Washington

    Seattle, WA

    Key Differentiators

    • Psychiatry
    • Maternal-Fetal Medicine
    • Epidemiology

Original Source(s)

Top FDA official seeks to hire friend pushing new antidepressants warning

  • by Matthew Perrone

  • March 4, 2026

Related Content

NPs Top US Jobs List Again

The nurse practitioner profession claims the No. 1 spot across three categories in the U.S. News & World Report 2026 Best Jobs rankings for the third consecutive year.

Hospital Prices Posted. Few Patients Look.

Federal rules require hospitals to post prices so patients can shop. Instead, insurers and providers use the data to negotiate what they get paid.

Fabricated Citations Are Reaching Medical Journals

A large audit of biomedical publications suggests fabricated references are increasingly appearing in peer-reviewed papers — often in ways that are difficult for reviewers and readers to detect.